Abbas, B., Marotta, P. L., Goddard-Eckrich, D., Huang, D., Schnaidt, J., El-Bassel, N., & Gilbert, L. (2021). Socio-ecological and pharmacy-level factors associated with naloxone stocking at standing-order naloxone pharmacies in New York CityDrug and Alcohol Dependence218, 108388.

Aivadyan, C., Lee, Y. G., El-Bassel, N., & Wu, E. (2021). Substance Use and Sexual Risk Behavior Among Black Men Who Have Sex with Men in New York City: Evidence for Increased Risk During Young AdulthoodAIDS Education and Prevention: Official Publication of the International Society for AIDS Education33(1), 73.

Allen, B., Basaraba, C., Corbeil, T., Rivera, B. D., Levin, F. R., Martinez, D., Schultebraucks, K., Henry, B. F., Pincus, H. A., Arout, C., & Krawczyk, N. Racial differences in COVID-19 severity associated with substance use disorders and drug overdose. Preventive Medicine, invited for resubmission.

Arout, C. A., Haney, M., Herrmann, E. S., Bedi, G., & Cooper, Z. D. (2022). A placebo‐controlled investigation of the analgesic effects, abuse liability, safety and tolerability of a range of oral cannabidiol doses in healthy humansBritish Journal of Clinical Pharmacology88(1), 347-355.

Barbosa‐Leiker, C., Campbell, A. N., McHugh, R. K., Guille, C., & Greenfield, S. F. (2021). Opioid use disorder in women and the implications for treatment. Psychiatric Research Clinical Practice, 3(1), 3-11.

Blevins, D., Henry, B. F., Sung, M., Edelman, E. J., Black, A. C., Dawes, M., Molfenter, T., Hagle, H., Cates-Wessel, K., & Levin, F. R. (2022). Well-being of health care professionals treating opioid use disorder during the COVID-19 pandemic: results from a national survey. Psychiatric Services, 73(4), 374-380.

Brandt, L., Campbell, A. N., Jones, J. D., Martinez, S., Neale, J., Parkin, S., Brown, C., Strang, J., & Comer, S. D. (2022). Emotional reactions of trained overdose responders who use opioids following intervention in an overdose eventSubstance Abuse43(1), 581-591.

Brandt, L., Yanagida, T., Campbell, A. N., Jones, J. D., Schultes, M. T., Martinez, S., & Comer, S. D. (2021). Multi-informant implementation and intervention outcomes of opioid overdose education and naloxone distribution in New York CityGlobal Implementation Research and Applications1(3), 209-222.

Davis, A., Pala, A. N., Nguyen, N., Robbins, R. N., Joska, J., Gouse, H., Mellins, C. A., Myer, L., Henry, M., Leu, C. S., & Remien, R. H. (2021). Sociodemographic and psychosocial predictors of longitudinal antiretroviral therapy (ART) adherence among first-time ART initiators in Cape Town, South AfricaAIDS Care33(11), 1394-1403.

El-Bassel, El-Bassel, N., Gilbert, L., Hunt, T., Wu, E., Oga, E. A., Mukherjee, T. I., Campbell, A. N. C., Sabounchi, N., Gutnick, D., Kerner, R., Venner, K. L., Lounsbury, D., Huang, T. T. K., & Rapkin, B. (2021). Using community engagement to implement evidence-based practices for opioid use disorder: a data-driven paradigm & systems science approachDrug and Alcohol Dependence222, 108675.

El-Bassel, N., Gilbert, L., Hunt, T., Wu, E., Oga, E. A., Mukherjee, T., Campbell, A. N. C., Sabounchi, N., Gutnick, D., Kerner, R., Venner, K. L., Lounsbury, D., Huang, T. T. K., & Rapkin, B. (2021). Using community engagement to implement evidence-based practices for opioid use disorder: A data-driven paradigm & systems science approach. Drug and Alcohol Dependence, 222, 108675.

El-Bassel, N., Hochstatter, K. R., Slavin, M.N., Yang, C., Zhang, Y., & Muresan, S. (2022). Harnessing the power of social media to understand the impact of COVID-19 on people who use drugs during lockdown and social distancing. Journal of Addiction Medicine, 16(2).

El-Bassel, N., Hunt, T., Goddard-Eckrich, D. A., Chang, M., McCrimmon, T. R., Mukherjee, T., Remien, R. H., Terlikbayeva, A., Primbetova, S., Davis, A>, Jiwatram-Negrón, T., Benjamin, S. N., Witte, S. S., Wu, E., & Gilbert, L. (2022). Couple-Based Behavioral HIV Interventions by the Social Intervention Group: Progress, Gaps, and Future DirectionsResearch on Social Work Practice, 10497315221118850.

El-Bassel, N., McCrimmon, T., Mergenova, G., Chang, M., Terlikbayeva, A., Primbetova, S., Kuskulov, A., Baiserkin, B., Denebayeva, A., Kurmetova, K., & Witte, S. S. (2021). A cluster-randomized controlled trial of a combination HIV risk reduction and microfinance intervention for female sex workers who use drugs in KazakhstanJournal of the International AIDS Society, 24(5), e25682.

El-Bassel, N., McCrimmon, T., Wu, E., Chang, E. , Terlikbayea, A., Hunt, T.,   Primbetova, S., Davis, A.,  Metsch, L., Feaster. D. J., Baiserkin, B., Abishev, A., Denebayeva, A., Sagimbayev, B., Kurmetova, K., Kozhakhmet, M., & Gilbert, L. (2022).  Effectiveness of an intervention to improve HIV service delivery for people who inject drugs in Kazakhstan Cluster TrialJAMA Network Open, 5(12), e2244734.

El-Bassel, N., Mukherjee, T. I., Stoicescu, C., Starbird, L. E., Stockman, J. K., Frye, V., & Gilbert, L. (2022). Intertwined epidemics: progress, gaps, and opportunities to address intimate partner violence and HIV among key populations of womenThe Lancet HIV, 9(3), e202-e213.

El-Bassel, N., Shoptaw, S., Goodman-Meza, D., Ono, H. (2021). Addressing long overdue social and structural determinants of the opioid epidemicDrug and Alcohol Dependence, 222, 108679.

Finnell, D. S., Soltis-Jarrett, V., Bratberg, J., Muzyk, A., Liu, Y., Edens, E., Seale, J. P., Mattingly, J., Schnurman, K., Osborne-Leute, V., Zweben, A., Cary, A. & Moore, B. A. (2022). Substance use–related continuing education course objectives: Alignment with professional competenciesSubstance Abuse43(1), 1363-1369.

Fishman, M., Wenzel, K., Scodes, J., Pavlicova, M., Campbell, A. N., Rotrosen, J., & Nunes, E. (2021). Examination of Correlates of OUD Outcomes in Young Adults: Secondary Analysis from the XBOT TrialThe American Journal on Addictions30(5), 433-444.

Gilbert, L., Goddard-Eckrich, D., Chang, M., Hunt, T., Wu, E., Johnson, K., Richards, S., Goodwin, S., Tibbetts, R., Metsch, L. R., & El-Bassel, N. (2021). Effectiveness of a culturally tailored HIV and sexually transmitted infection prevention intervention for Black women in community supervision programs: A randomized clinical trialJAMA Network Open, 4(4), e215226.

Gilbert, L., Marotta, P. L., Goddard-Eckrich, D., Richer, A., Akuffo, J., Hunt, T., Wu, E., & El-Bassel, N. (2022). Association between multiple experiences of violence and drug overdose among Black women in community supervision programs in New York CityJournal of Interpersonal Violence37(23-24), NP21502-NP21524.

Greiner, M. G., Shulman, M., Choo, T. H., Scodes, J., Pavlicova, M., Campbell, A. N., Novo, P., Fishman, M., Lee, J. D., Rotrosen, J., & Nunes, E. V. (2021). Naturalistic follow-up after a trial of medications for opioid use disorder: Medication status, opioid use, and relapse. Journal of Substance Abuse Treatment131, 108447.

Greiner, M. G., Shulman, M., Scodes, J., Choo, T. H., Pavlicova, M., Opara, O., Campbell, A. N. C., Novo, P., Fishman, M., Lee, J. D., Rotrosen, J., & Nunes, E. V. (2022). Patient Characteristics Associated with Opioid Abstinence after Participation in a Trial of Buprenorphine versus Injectable NaltrexoneSubstance Use & Misuse57(11), 1732-1742.

Henry, B. F., Campbell, A. N. C., Hunt, T., Johnson, J. K., Mandavia, A. D., Chaple, M., Arout, C., Wu, E., Pincus, H. A., Nunes, E. V., Lincourt, P., Levin, F. R., El-Bassel, N. (2022). COVID-19 related substance use services policy changes: Policymaker perspectives on policy development & implementation. Journal of Substance Abuse Treatment, 133.

Hochstatter, K. R., Slavin, M. N., Gilbert, L., Goddard-Eckrich, D., & El-Bassel, N. (2022). Availability of informal social support and the impact on health services utilization among women in community corrections who engage in substance use and risky sexual behavior: New York City, 2009–2012Health & Justice10(1), 1-12.

Kiluk, B. D., Kleykamp, B. A., Comer, S. D., Griffiths, R. R., Huhn, A. S., Johnson, M. W., Kampman, K. M., Pravetoni, M., Preston, K. L., Vandrey, R>, Bergeria, C. L., Bogenschutz, M. P., Brown, R. T., Dunn, K. E., Dworkin, R. H., Finan, P. H., Hendricks, P. S., Houtsmuller, E. J., Kosten, T. R., Lee, D. C., Levin, F. R., McRae-Clark, A., Raison, C. L., Rasmussen, K., Turk, D. C., Weiss, R. D., & Strain, E. C. (2023). Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder: A ReviewJAMA Psychiatry, 80(1), 84-92.

Krawczyk, N., Rivera, B. D., Basaraba, C., Corbeil, T., Allen, B., Schultebraucks, K., Henry, B. F., Pincus, H. A., Levin, F. R., & Martinez, D. M. (Accepted, in press). COVID-19 complications among patients with opioid use disorder: A retrospective cohort study across five major urban hospital systemsAddiction, online ahead of print.

Krawczyk, N., Williams, A. R., Saloner, B., & Cerdá, M. (2021). Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settingsJournal of Substance Abuse Treatment126, 108329.

Lee, Y. G., Zhakupova, G., Vinogradov, V., Paine, E. A., Laughney, C. I., Reeder, K., Davis, A., Hunt, T., Mergenova, G., Primbetova, S., Terlikbayeva, A., & Wu, E. (2022). Polydrug Use, Sexual Risk, and HIV Testing Among Cisgender Gay, Bisexual, and Other Men and Transgender and Nonbinary Individuals Who Have Sex with Men in KazakhstanAIDS Education and Prevention34(5), 413-426.

Levin, F. R., & Nunes, E. V. (2022). The Elephants in the Room: Why Physicians Are Not PrescribingPsychiatric Services73(5), 481-481.Rudolph, K. E., Russell, M., Luo, S. X., Rotrosen, J., & Nunes, E. V. (2022). Under-representation of key demographic groups in opioid use disorder trials. Drug and Alcohol Dependence Reports4, 100084.

Mandavia, A. D., Campbell, A. N. C., Henry, B., Chaple, M., Hunt, T., Arout, C., Wu, E., Pincus, H., Nunes, E., Lincourt, P., Levin, F., & El-Bassel, N. (2022). Support for COVID-19 Related Substance Use Services Policy Changes: A New York State-wide SurveyJournal of Behavioral Health Services & Research49(3), 262-281.

Marotta, P. L., Gilbert, L., Goddard-Eckrich, D., Hunt, T., Metsch, L., Davis, A., Feaster, D., Wu, E., & El-Bassel, N. (2021). A dyadic analysis of criminal justice involvement and sexual HIV risk behaviors among drug-involved men in community corrections and their intimate partners in New York City: implications for prevention, treatment, and policiesAIDS and Behavior25(4), 1047-1062.

Marotta, P. L., Stringer, K., Beletsky, L., West, B. S., Goddard-Eckrich, D., Gilbert, L., Hunt, T., Wu, E., & El-Bassel, N. (2021). Assessing the relationship between syringe exchange, pharmacy, and street sources of accessing syringes and injection drug use behavior in a pooled nationally representative sample of people who inject drugs in the United States from 2002 to 2019. Harm Reduction Journal, 18(1), 1-8.

Marotta, P. L., Terlikbayeva, A., Gilbert, L., Davis, A., Wu, E., Metsch, L., Feaster, D., & El-Bassel, N. (2021). Dyadic analysis of criminal justice involvement and HIV risks among couples who inject drugs and their intimate partners in Almaty, KazakhstanInternational Journal of Drug Policy87, 102950.

McCrimmon, T., Sundelson, A., Darisheva, M., Gilbert, L., Hunt, T., Terlikbayeva, A., Primbetova, S., & El-Bassel, N. (2022). HIV Care Continuum Services for People Who Inject Drugs in Kazakhstan During COVID-19: A Qualitative Study of Service Provider PerspectivesGlobal Health: Science and Practice10(2).

Mukherjee, T. I., Pala, A. N., Terlikbayeva, A., Davis, A., Howard, A. A., McCrimmon, T., Mergenova, G., Primbetova, S., Witte, S. S., & El-Bassel, N. (2022). Social and structural determinants of health associated with police violence victimization: A latent class analysis of female sex workers who use drugs in KazakhstanInternational Journal of Drug Policy106, 103750.

Nunes, E. V., Levin, F. R., Reilly, M. P., & El-Bassel, N. (2021). Medication treatment for opioid use disorder in the age of COVID-19: Can new regulations modify the opioid cascade? Journal of Substance Abuse Treatment122, 108196.

Parkin, S., Neale, J., Brown, C., Jones, J. D., Brandt, L., Castillo, F., Campbell, A. N. C., Strang, J., & Comer, S. D. (2021). A qualitative study of repeat naloxone administrations during opioid overdose intervention by people who use opioids in New York CityInternational Journal of Drug Policy87, 102968.

Paschen-Wolff, M. M., Campbell, A. N., Tross, S., Choo, T. H., Pavlicova, M., Braunstein, S., Lazar, R., Borges, C., Castro, M., Berg, H., Harriman, G., Remien, R. H., & Des Jarlais, D. (2022). Durable viral suppression among people with HIV and problem substance use in the era of universal antiretroviral treatmentAIDS and Behavior26(2), 385-396.

Paschen-Wolff, M. M., Velasquez, R., Aydinoglo, N., & Campbell, A. N. (2022). Simulating the experience of searching for LGBTQ-specific opioid use disorder treatment in the United StatesJournal of Substance Abuse Treatment140, 108828.

Reed, E., West, B. S., Frost, E., Salazar, M., Silverman, J. G., McIntosh, C. T., Gomez, M., G., R., Uraga, L. A., & Brouwer, K. C. (2022). Economic vulnerability, violence, and sexual risk factors for HIV among female sex workers in Tijuana, MexicoAIDS and Behavior, 1-10.

Rudolph, K. E., Díaz, I., Hejazi, N. S., van der Laan, M. J., Luo, S. X., Shulman, M., Campbell, A., Rotrosen, J., & Nunes, E. V. (2021). Explaining differential effects of medication for opioid use disorder using a novel approach incorporating mediating variables. Addiction, 116(8), 2094-2103.

Rudolph, K. E., Díaz, I., Luo, S. X., Rotrosen, J., & Nunes, E. V. (2021). Optimizing opioid use disorder treatment with naltrexone or buprenorphineDrug and Alcohol Dependence228, 109031.

Schultebraucks, K., Blekic, W., Basaraba, C., Corbeil, T., Khan, Z., Henry, B. F., Krawczyk, N., Rivera, B. D., Allen, B., Arout, C., Pincus, H. A., Martinez, D. M., & Levin, F. R. The impact of pre-existing psychiatric disorders and antidepressant use on COVID-19 related outcomes: A multicenter study. Molecular Psychiatry, invited for resubmission.

Seval, N., Frank, C. A., Litwin, A. H., Roth, P., Schade, M. A., Pavlicova, M., Levin, F. R., Brady, K. T., Nunes, E. V., & Springer, S. A. (2021). Design and methods of a multi-site randomized controlled trial of an integrated care model of long-acting injectable buprenorphine with infectious disease treatment among persons hospitalized with infections and opioid use disorderContemporary Clinical Trials105, 106394.

Stewart, A., West, B. S., Rafful, C., Lazos, K., Jain, J., Gonzalez-Zuniga, P., & Rocha-Jimenez, T. (2021). “I would rather do it myself”: injection initiation and current injection patterns among women who inject drugs in Tijuana, MexicoHarm Reduction Journal18(1), 1-11.

Sung, M. L., Black, A. C., Blevins, D., Henry, B. F., Cates-Wessel, K., Dawes, M. A., Drexler, K., Hagle, H., Molfenter, T., Levin, F. R., Becker, W. C., & Edelman, E. J. (2021). Adaptations to Opioid Use Disorder Care During the COVID-19 Pandemic: A National Survey of PrescribersJournal of Addiction Medicine16(5), 505-513.

Suri, A., Feaster, D. J., Balise, R. R., Quinn, J., Nunes, E. V., Gilbert, L., El-Bassel, N., & Rundle, A. G. (2022). Impacts of the New York State COVID‐19 Disaster Emergency Orders on prescription dispensing for opioids and medication for opioid use disorderAddiction, online ahead of print.

West, B. S., Henry, B. F., Agah, N., Vera, A., Beletsky, L., Rangel, M. G., Staines, H., Patterson, T. L., & Strathdee, S. A. (2022). Typologies and correlates of police violence against female sex workers who inject drugs at the México–United States Border: Limits of de jure decriminalization in advancing health and human rightsJournal of Interpersonal Violence37(11-12), NP8297-NP8324.

Williams, A. R. (2021). A critical charge for improving opioid use disorder outcomes along the cascade. The American Journal of Drug and Alcohol Abuse, 47(2), 141-143.

Williams, A. R., Aronowitz, S., Gallagher, R., Behar, E., Gray, Z., & Bisaga, A. (2022). A Virtual-First Telehealth Treatment Model for Opioid Use DisorderJournal of General Internal Medicine, 1-3, online ahead of print.

Williams, A. R., Johnson, K. A., Thomas, C. P., Reif, S., Socías, M. E., Henry, B. F., Neighbors, C., Gordon, A. J., Horgan, C., Nosyk, B., Drexler, K., Krawczyk, N., Gonsalces, G. S., Hadland, S. E., Stein, B. D., Fishman, M., Keley, A. T., Pimcus, H. A., & Olfson, M. (2022). Opioid use disorder Cascade of care framework design: A roadmapSubstance Abuse43(1), 1207-1214.

Williams, A. R., Mauro, C. M., Feng, T., Waples, J., Martins, S. S., & Haney, M. (2022). Adult Medical Cannabinoid Use and Changes in Prescription Controlled Substance UseCannabis and Cannabinoid Research, online ahead of print.

Williams, A. R., Mauro, C. M., Feng, T., Wilson, A., Cruz, A., Olfson, M., Crystal, S., Samples, H., & Chiodo, L. (2022). Performance Measurement for Opioid Use Disorder Medication Treatment and Care Retention. American Journal of Psychiatry, online ahead of print.

Williams, A. R., Mauro, C. M., Feng, T., Wilson, A., Cruz, A., Olfson, M., Crystal, S., Samples, H., & Chiodo, L. (2022). Non–prescribed buprenorphine preceding treatment intake and clinical outcomes for opioid use disorderJournal of Substance Abuse Treatment, 108770.